Redwood City, CA, United States of America

Wenwu Zhai

USPTO Granted Patents = 12 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 17(Granted Patents)

Company Filing History:

5 out of 52

Rinat Neuroscience Corporation

patents

4 out of 73

Ngm Biopharmaceuticals, Inc.

Years Active: 2012-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11767359 - C3-binding agents and methods of use thereof (2023-09-26),

2. 11725050 - Anti-interleukin-33 antibodies and uses thereof (2023-08-15),

3. 11566067 - Methods of lowering triglyceride levels with an ANGPTL8-binding antibody or antigen-binding fragment thereof (2023-01-31),

4. 11136381 - Anti-C3 antibodies (2021-10-05),

5. 10774139 - ANGPTL8-binding agents and methods of use thereof (2020-09-15),

6. 10723795 - Anti-interleukin-33 antibodies and uses thereof (2020-07-28),

7. 10093730 - Anti-interleukin-33 antibodies and uses thereof (2018-10-09),

8. 10059772 - Antagonist anti-IL-7 receptor antibodies and methods (2018-08-28),

9. 9346885 - Method of treating type 1 diabetes with antagonist IL-7 receptor antibodies (2016-05-24),

10. 8715673 - [object Object] (2014-05-06),

11. 8637273 - Nucleic acid encoding IL-7 receptor alpha antibody (2014-01-28),

12. 8298535 - Anti-IL-7 receptor antibodies (2012-10-30),

Title: The Inventive Mind of Wenwu Zhai: Revolutionizing Biopharmaceutical Innovation

Introduction:

Wenwu Zhai, a brilliant inventor based in Redwood City, CA, has made significant strides in the field of biopharmaceutical innovation. With an impressive portfolio of 12 patents under his belt, Zhai is a visionary in the development of cutting-edge medical treatments.

Latest Patents:

Zhai's latest patents showcase his expertise in developing groundbreaking medical solutions. One of his recent inventions includes C3-binding agents, which are antibodies designed to specifically bind complement component C3. Additionally, Zhai has also pioneered the creation of anti-interleukin-33 antibodies, opening up new possibilities in the realm of immunotherapy.

Career Highlights:

Throughout his career, Wenwu Zhai has made significant contributions to companies at the forefront of biopharmaceutical research. Notably, he has worked with Rinat Neuroscience Corporation and NGM Biopharmaceuticals, Inc., where his innovative spirit has helped drive the development of novel therapies.

Collaborations:

In his quest for innovation, Zhai has collaborated with esteemed colleagues such as Zhonghao Liu and Yan Wang. Together, they have pushed the boundaries of what is possible in the realm of biopharmaceuticals, paving the way for a healthier future.

Conclusion:

Wenwu Zhai's trailblazing work in the field of biopharmaceutical innovation is nothing short of remarkable. His relentless pursuit of novel medical solutions has not only earned him recognition within the industry but has also made a significant impact on the lives of patients worldwide. As he continues to push the boundaries of what is possible, the world eagerly anticipates the next groundbreaking invention from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.